<DOC>
	<DOC>NCT01484951</DOC>
	<brief_summary>The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.</brief_summary>
	<brief_title>AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Clinical diagnosis of ocular hypertension, primary openangle or pigment dispersion glaucoma in both eyes. Must be on a stable regimen of intraocular pressure (IOP) lowering medication within one week of screening/baseline visit. Must have an IOP of between 19 and 35 mmHg (both inclusive) in at least one eye, which would be the study eye, at screening. Must be willing to discontinue the use of all other ocular hypotensive medications prior to receiving the study medication for the entire course of the study. Must have best corrected visual acuity of 6/60 (20/200 Snellen, 1.0 LogMAR) or better in each eye. Other protocoldefined inclusion criteria may apply. Known medical history of allergy, hypersensitivity, or poor tolerance to any component of the medication to be used in the study deemed clinically significant in the opinion of the principal investigator. Any abnormality preventing reliable applanation tonometry in either eye. Risk of visual field or visual acuity worsening as a consequence of participating in this study, in the investigator's best judgment. Pregnant or lactating. Participation in any other investigational study within 30 days of screening visit. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>Pigment dispersion glaucoma</keyword>
</DOC>